Allegro Diagnostics, Inc. is a molecular diagnostics company that uses proprietary technology and bioinformatics to diagnose diseases of epithelial origin. Allegro developed a genetic test that diagnoses cancer in smokers and ex-smokers without requiring a lung tissue sample, greatly reducing morbidity and mortality associated with puncturing the lung for biopsy.